Michael Combs; President, Chief Executive Officer; CorVel Corp. Brandon O'Brien; Chief Financial Officer; CorVel Corp. Presentation. Operator. Thank you for standing ...

On November 5, the US Food and Drug Administration (FDA) updated the labels for all glucagon-like peptide 1 receptor agonists (GLP-1 RA) with a warning about pulmonary aspiration during general ...

The majority of patients may safely take glucagon-like peptide 1 receptor agonists (GLP-1 RAs) before elective surgery and gastrointestinal endoscopies, according to updated guidance from five ...

Negotiations on the sale of a stake in GLP Pte’s China operations to Guangdong Holdings Ltd. have stalled due to disagreements over deal terms, according to people familiar with the situation.

Share on Pinterest A recent study found significant reductions in opioid overdose and alcohol misuse among people taking GLP-1 drugs like Ozempic. FreshSplash/Getty Images A new study shows a 50% ...

A new class of drugs is set to join their ranks and has the potential to eclipse them all—GLP-1 receptor agonists ... That does happen, of course, but research shows that it is not the full ...

But in the last few years, with the approval of GLP-1 drugs like Wegovy and Zepbound, more and more people are opting for obesity medicines over gold-standard surgical treatments. “On a ...

The study found a sharp increase in the share of patients who received GLP-1 RAs during the study period, with GLP-1 RA use increasing 132.6% from the last six months of 2022 to the last six ...

Here are 8 expert ways to naturally supercharge your GLP-1. Karan Johar’s alleged Ozempic drug use: How to naturally boost GLP-1 levels for healthy weight loss (Photo for representative purpose ...

Could these medications — collectively known as GLP-1 receptor agonists — also fight America’s most difficult drug problems? Striking new data suggests they might. On Thursday, the journal ...

Novo Nordisk's GLP-1 medication, Rybelsus, reduced major adverse cardiovascular events by 14% compared to a placebo in a phase 3 trial, the drugmaker said Oct. 21. Rybelsus, a daily pill approved ...